Scinovex
article Open AccessTop 1% cited

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

New England Journal of Medicine · 2005 · Vol. 352(10) · pp. 987–996
Roger StuppWarren MasonMartin J. van den BentMichael WellerBarbara FisherMartin TaphoornKarl BélangerAlba A. BrandesChristine MarosiUlrich BogdahnJürgen CurschmannRobert C. JanzerSamuel K. LudwinThierry GorliaAnouk AllgeierDenis LacombeJ. Gregory CairncrossElizabeth A. EisenhauerR.O. Mirimanoff

Abstract

The addition of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clinically meaningful and statistically significant survival benefit with minimal additional toxicity.

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMedical Imaging Techniques and ApplicationsTemozolomideMedicineRadiation therapyConcomitantGlioblastomaAdjuvantAdjuvant radiotherapyOncologyInternal medicineSurgery

MeSH terms

TemozolomideAdrenal Cortex HormonesAdultAgedBrain NeoplasmsDacarbazineFemaleGlioblastomaHumansMaleMiddle AgedRadiotherapy, Computer-AssistedProportional Hazards ModelsSurvival AnalysisChemotherapy, Adjuvant
Citations
21,276
FWCI
172.61
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Related articles
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.